- Home
- AADI vs ANIX Comparison
AADI vs ANIX Comparison
Compare AADI & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AADI
- ANIX
- Stock Information
- Founded
- AADI 2011
- ANIX 1982
- Country
- AADI United States
- ANIX United States
- Employees
- AADI N/A
- ANIX N/A
- Industry
- AADI Biotechnology: Pharmaceutical Preparations
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- AADI Health Care
- ANIX Health Care
- Exchange
- AADI Nasdaq
- ANIX Nasdaq
- Market Cap
- AADI 77.5M
- ANIX 82.7M
- IPO Year
- AADI N/A
- ANIX 1987
- Fundamental
- Price
- AADI $2.79
- ANIX $3.08
- Analyst Decision
- AADI Hold
- ANIX Strong Buy
- Analyst Count
- AADI 3
- ANIX 2
- Target Price
- AADI $1.75
- ANIX $8.50
- AVG Volume (30 Days)
- AADI 114.1K
- ANIX 120.2K
- Earning Date
- AADI 03-12-2025
- ANIX 03-11-2025
- Dividend Yield
- AADI N/A
- ANIX N/A
- EPS Growth
- AADI N/A
- ANIX N/A
- EPS
- AADI N/A
- ANIX N/A
- Revenue
- AADI $25,070,000.00
- ANIX N/A
- Revenue This Year
- AADI $8.43
- ANIX N/A
- Revenue Next Year
- AADI $5.41
- ANIX N/A
- P/E Ratio
- AADI N/A
- ANIX N/A
- Revenue Growth
- AADI 7.80
- ANIX N/A
- 52 Week Low
- AADI $1.21
- ANIX $2.07
- 52 Week High
- AADI $3.81
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- AADI 48.57
- ANIX 55.10
- Support Level
- AADI $2.56
- ANIX $2.78
- Resistance Level
- AADI $2.94
- ANIX $3.30
- Average True Range (ATR)
- AADI 0.13
- ANIX 0.21
- MACD
- AADI 0.01
- ANIX -0.01
- Stochastic Oscillator
- AADI 57.50
- ANIX 66.15
About AADI Aadi Bioscience Inc.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.